Diarmuid Moran

Head of Precision Medicine & Diagnostics (R&D) Astellas Pharma

Seminars

Wednesday 7th October 2026
Panel Discussion: Innovating Global Rx-Dx Trial Pathways Through Strategic & Compliant Co-Development Partnerships to Deliver Harmonized Precision Medicine Solutions
3:10 pm
  • When and how should biomarker evidence maturity trigger formal CDx development to ensure alignment with therapeutic strategy, clinical endpoints, and global regulatory expectations?
  • How can organizations define and evolve CDx strategies that align with clinical trial design and biomarker science while accommodating regional variability in regulation, testing infrastructure, and clinical practice?
  • What cross-functional models, partnerships, and data strategies are needed to embed CDx considerations seamlessly across the drug development lifecycle and enable synchronized evidence generation and assay readiness?

Right click on the image to save it to your computer.

Diarmuid_Muran[1]
View all Speakers
View Event Brochure